Secondary Logo

Institutional members access full text with Ovid®

Share this article on:

A Systematic Review and Meta-Analysis on the Prevalence of Dupuytren Disease in the General Population of Western Countries

Lanting, Rosanne M.D.; Broekstra, Dieuwke C. M.Sc.; Werker, Paul M. N. M.D., Ph.D.; van den Heuvel, Edwin R. Ph.D.

Erratum

In the March 2014 Hand/Peripheral Nerve article entitled “A Systematic Review and Meta-Analysis on the Prevalence of Dupuytren Disease in the General Population of Western Countries” by Lanting et al. (Plast Reconstr Surg. 2014;133:593–603), on page 594, in the Patients and Methods section, in paragraph 2, the first sentence had an incorrect year. The sentence should have read as follows (correction in italics): “The search was updated on January 24, 2013, and supplemented by automatically weekly derived updates from PubMed until August 4, 2013.”

Plastic and Reconstructive Surgery. 133(5):1312, May 2014.

Plastic and Reconstructive Surgery: March 2014 - Volume 133 - Issue 3 - p 593–603
doi: 10.1097/01.prs.0000438455.37604.0f
Hand/Peripheral Nerve: Original Articles

Background: Dupuytren disease is a fibroproliferative disease of palmar fascia of the hand. Its prevalence has been the subject of several reviews; however, an accurate description of the prevalence range in the general population—and of the relation between age and disease—is lacking.

Methods: Embase and PubMed were searched using database-specific Medical Subject Headings; titles and abstracts were searched for the words “Dupuytren,” “incidence,” and “prevalence.” Two reviewers independently assessed the articles using inclusion and exclusion criteria, and rated the included studies with a quality assessment instrument. In a meta-analysis, the median prevalence, as a function of age by sex, was estimated, accompanied by 95 percent prediction intervals. The observed heterogeneity in prevalence was investigated with respect to study quality and geographic location.

Results: Twenty-three of 199 unique identified articles were included. The number of participants ranged from 37 to 97,537, and age ranged from 18 to 100 years. Prevalence varied from 0.6 to 31.6 percent. The quality of studies differed but could not explain the heterogeneity among studies. Mean prevalence was estimated as 12, 21, and 29 percent at ages 55, 65, and 75 years, respectively, based on the relation between age and prevalence determined from 10 studies.

Conclusions: The authors describe a prevalence range of Dupuytren disease in the general population of Western countries. The relation between age and prevalence of Dupuytren disease is given according to sex, including 95 percent prediction intervals. It is possible to determine disease prevalence at a certain age for the total population, and for men and women separately.

Groningen, The Netherlands

From the Departments of Plastic Surgery and Epidemiology, University of Groningen, University Medical Center Groningen.

Received for publication August 6, 2013; accepted September 19, 2013.

The first two authors contributed equally to this article.

Disclosure: Dr. Werker is a consultant for Pfizer. Dr. van den Heuvel is a consultant for Merck. The other authors have no financial or other interest in any of the products, devices, or drugs mentioned in this article.

Rosanne Lanting, M.D., Department of Plastic Surgery, HPC BB81, P.O. Box 30.001, 9700 RB Groningen, The Netherlands, r.lanting@umcg.nl

©2014American Society of Plastic Surgeons